Cannabis terpenes display variable protective and anti-aggregatory actions against neurotoxic β amyloid in vitro: highlighting the protective bioactivity of α-bisabolol in motorneuronal-like NSC-34 cells

Terpenes form a diverse class of naturally occurring chemicals ascribed various biological activities. Cannabis contains over 400 different terpenes of varying chemical complexity which may add to the known biological activities of phytocannabinoids of relevance to the increasing use of medical cann...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurotoxicology (Park Forest South) 2022-05, Vol.90, p.81-87
Hauptverfasser: Laws III, John Staton, Shrestha, Srijan, Smid, Scott D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 87
container_issue
container_start_page 81
container_title Neurotoxicology (Park Forest South)
container_volume 90
creator Laws III, John Staton
Shrestha, Srijan
Smid, Scott D.
description Terpenes form a diverse class of naturally occurring chemicals ascribed various biological activities. Cannabis contains over 400 different terpenes of varying chemical complexity which may add to the known biological activities of phytocannabinoids of relevance to the increasing use of medical cannabis; however, to date have been incompletely characterized. We assessed three terpenes predominant in cannabis: α-bisabolol, myrcene and β-caryophyllene for neuroprotective and anti-aggregative properties in both undifferentiated and differentiated NSC-34 motorneuronal-like cells as a sensitive model for neurotoxicity to oxidative stress and amyloid β (Aβ1–42) protein exposure. Cell viability was assessed biochemically using the MTT assay in the presence of either α-bisabolol, myrcene and β-caryophyllene (1–1000 µM) for 48 hr. Sub-toxic threshold test concentrations of each terpene were then applied to cells, alone or with concomitant incubation with the lipid peroxidant tert-butyl hyrdroperoxide (t-BHP) or amyloid β (Aβ1–42; 0–1 µM) to assess neuroprotective effects. Direct effects of each terpene on Aβ fibril formation and aggregation were also evaluated using the Thioflavin T (ThT) fluorometric kinetic assay, circular dichroism and transmission electron microscopy (TEM) to visualise fibril and aggregate morphology. Terpenes were intrinsically benign to NSC-34 cells up to 100 µM. No significant antioxidant effects were observed following t-BHP administration with myrcene and β-caryophyllene, however α-bisabolol provided a modest but significant increase in cell viability in undifferentiated cells. α-bisabolol also demonstrated a significant neuroprotective effect against amyloid β exposure, with β-caryophyllene also providing a lesser, but significant increase in cell viability. Protective effects of terpenes were more pronounced in undifferentiated versus differentiated cells, attributable more so to an attenuated loss of cell viability in response to Aβ1–42 following NSC-34 cell differentiation. Neuroprotection was associated with a direct inhibition of Aβ1–42 fibril and aggregate density, evidenced by both attenuated ThT fluorescence kinetics and both spectral and microscopic evidence of altered and diminished density of Aβ aggregates. While myrcene and β-caryophyllene also elicited reductions in ThT fluorescence and alterations in Aβ aggregation, these were less well associated with neuroprotective capacity. These findings highlight a neuroprotective role
doi_str_mv 10.1016/j.neuro.2022.03.001
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2638725334</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0161813X22000377</els_id><sourcerecordid>2638725334</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-83706f969c3bf3171209697a155a8367007085e96f3c4892947c3008e1db7b923</originalsourceid><addsrcrecordid>eNp9kc-q1DAUxoso3vHqEwgScOOmNX_aJhVcyOA_uOhCBXchbU87GdNkTNLBPpa-h_eZTGeugi5cHELI73zny_my7CHBBcGkfrovLMzeFRRTWmBWYExuZRsiOM0bTsjtbJMokgvCPl9k90LYJ6DidXM3u2AV5aKi5Sb7uVXWqlYHFMEfwEJAvQ4HoxZ0VF6r1gA6eBehi_oISNk-VdS5GkcPo4rOL0ilN2cDUqPSNkR0shXdN92h6x9ITYtxukfaoqOO3j1DOz3uTKqo7Yji7q8BrXarXCIX5AZ0_T1P3lTrjDOrwpR0_UnfKpMb_QXQuw_bnJWoA2PC_ezOoEyABzfnZfbp1cuP2zf51fvXb7cvrvKOCR5zwTiuh6ZuOtYOjHBCcbpwRapKCVZzjDkWFTT1wLpSNLQpeccwFkD6lrcNZZfZk7Nucv51hhDlpMPqQFlwc5C0TnNoxViZ0Mf_oHs3--R-pXgp6rIWPFHsTHXeheBhkAevJ-UXSbBc05Z7efq2XNOWmMkUZup6dKM9txP0f3p-x5uA52cA0jKOGrwMnQbbQa99Wrjsnf7vgF8OqsFW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2674864687</pqid></control><display><type>article</type><title>Cannabis terpenes display variable protective and anti-aggregatory actions against neurotoxic β amyloid in vitro: highlighting the protective bioactivity of α-bisabolol in motorneuronal-like NSC-34 cells</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Laws III, John Staton ; Shrestha, Srijan ; Smid, Scott D.</creator><creatorcontrib>Laws III, John Staton ; Shrestha, Srijan ; Smid, Scott D.</creatorcontrib><description>Terpenes form a diverse class of naturally occurring chemicals ascribed various biological activities. Cannabis contains over 400 different terpenes of varying chemical complexity which may add to the known biological activities of phytocannabinoids of relevance to the increasing use of medical cannabis; however, to date have been incompletely characterized. We assessed three terpenes predominant in cannabis: α-bisabolol, myrcene and β-caryophyllene for neuroprotective and anti-aggregative properties in both undifferentiated and differentiated NSC-34 motorneuronal-like cells as a sensitive model for neurotoxicity to oxidative stress and amyloid β (Aβ1–42) protein exposure. Cell viability was assessed biochemically using the MTT assay in the presence of either α-bisabolol, myrcene and β-caryophyllene (1–1000 µM) for 48 hr. Sub-toxic threshold test concentrations of each terpene were then applied to cells, alone or with concomitant incubation with the lipid peroxidant tert-butyl hyrdroperoxide (t-BHP) or amyloid β (Aβ1–42; 0–1 µM) to assess neuroprotective effects. Direct effects of each terpene on Aβ fibril formation and aggregation were also evaluated using the Thioflavin T (ThT) fluorometric kinetic assay, circular dichroism and transmission electron microscopy (TEM) to visualise fibril and aggregate morphology. Terpenes were intrinsically benign to NSC-34 cells up to 100 µM. No significant antioxidant effects were observed following t-BHP administration with myrcene and β-caryophyllene, however α-bisabolol provided a modest but significant increase in cell viability in undifferentiated cells. α-bisabolol also demonstrated a significant neuroprotective effect against amyloid β exposure, with β-caryophyllene also providing a lesser, but significant increase in cell viability. Protective effects of terpenes were more pronounced in undifferentiated versus differentiated cells, attributable more so to an attenuated loss of cell viability in response to Aβ1–42 following NSC-34 cell differentiation. Neuroprotection was associated with a direct inhibition of Aβ1–42 fibril and aggregate density, evidenced by both attenuated ThT fluorescence kinetics and both spectral and microscopic evidence of altered and diminished density of Aβ aggregates. While myrcene and β-caryophyllene also elicited reductions in ThT fluorescence and alterations in Aβ aggregation, these were less well associated with neuroprotective capacity. These findings highlight a neuroprotective role of α-bisabolol against Aβ-mediated neurotoxicity associated with an inhibition of Aβ fibrillization and modest antioxidant effect against lipid peroxidation, while β-caryophyllene also provided a small but significant measure of protection to Aβ-mediated neurotoxicity. Anti-aggregatory effects were not directly correlated with neuroprotective efficacy. This demonstrates that bioactivity of selected terpenes should be a consideration in the emergent use of medicinal cannabis formulations for the treatment of neurodegenerative diseases. [Display omitted] •Cannabis terpenes may have additional bioactivity to complement phytocannabinoids.•α-bisabolol and β-caryophyllene but not myrcene protected neuronal NSC-34 cells against neurotoxic amyloid β.•Neuroprotection was accompanied by modest attenuation in Aβ aggregation.•Bioactivity of terpenes may contribute to benefits of medicinal cannabis use in dementia and other CNS disorders.</description><identifier>ISSN: 0161-813X</identifier><identifier>EISSN: 1872-9711</identifier><identifier>DOI: 10.1016/j.neuro.2022.03.001</identifier><identifier>PMID: 35278524</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Agglomeration ; Amyloid beta-Peptides - metabolism ; Amyloid beta-Peptides - toxicity ; Amyloid β ; Animals ; Antioxidants ; Biocompatibility ; Biological activity ; Cannabis ; Caryophyllene ; Cell differentiation ; Cell viability ; Circular dichroism ; Cytology ; Density ; Dichroism ; Differentiation (biology) ; Fibrillogenesis ; Fluorescence ; Hallucinogens ; Incubation ; Lipid peroxidation ; Lipids ; Medical marijuana ; Monocyclic Sesquiterpenes ; Myrcene ; Myrcene, β-caryophyllene ; Neurodegenerative diseases ; Neuroprotection ; Neuroprotective Agents - chemistry ; Neuroprotective Agents - pharmacology ; Neurotoxicity ; Neurotoxicity Syndromes - prevention &amp; control ; NSC-34 ; Oxidative stress ; PC12 Cells ; Peptide Fragments - toxicity ; Peroxidation ; Rats ; Terpenes ; Terpenes - toxicity ; Toxicity testing ; Transmission electron microscopy ; α-bisabolol</subject><ispartof>Neurotoxicology (Park Forest South), 2022-05, Vol.90, p.81-87</ispartof><rights>2022</rights><rights>Crown Copyright © 2022. Published by Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier BV May 2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-83706f969c3bf3171209697a155a8367007085e96f3c4892947c3008e1db7b923</citedby><cites>FETCH-LOGICAL-c387t-83706f969c3bf3171209697a155a8367007085e96f3c4892947c3008e1db7b923</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.neuro.2022.03.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35278524$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Laws III, John Staton</creatorcontrib><creatorcontrib>Shrestha, Srijan</creatorcontrib><creatorcontrib>Smid, Scott D.</creatorcontrib><title>Cannabis terpenes display variable protective and anti-aggregatory actions against neurotoxic β amyloid in vitro: highlighting the protective bioactivity of α-bisabolol in motorneuronal-like NSC-34 cells</title><title>Neurotoxicology (Park Forest South)</title><addtitle>Neurotoxicology</addtitle><description>Terpenes form a diverse class of naturally occurring chemicals ascribed various biological activities. Cannabis contains over 400 different terpenes of varying chemical complexity which may add to the known biological activities of phytocannabinoids of relevance to the increasing use of medical cannabis; however, to date have been incompletely characterized. We assessed three terpenes predominant in cannabis: α-bisabolol, myrcene and β-caryophyllene for neuroprotective and anti-aggregative properties in both undifferentiated and differentiated NSC-34 motorneuronal-like cells as a sensitive model for neurotoxicity to oxidative stress and amyloid β (Aβ1–42) protein exposure. Cell viability was assessed biochemically using the MTT assay in the presence of either α-bisabolol, myrcene and β-caryophyllene (1–1000 µM) for 48 hr. Sub-toxic threshold test concentrations of each terpene were then applied to cells, alone or with concomitant incubation with the lipid peroxidant tert-butyl hyrdroperoxide (t-BHP) or amyloid β (Aβ1–42; 0–1 µM) to assess neuroprotective effects. Direct effects of each terpene on Aβ fibril formation and aggregation were also evaluated using the Thioflavin T (ThT) fluorometric kinetic assay, circular dichroism and transmission electron microscopy (TEM) to visualise fibril and aggregate morphology. Terpenes were intrinsically benign to NSC-34 cells up to 100 µM. No significant antioxidant effects were observed following t-BHP administration with myrcene and β-caryophyllene, however α-bisabolol provided a modest but significant increase in cell viability in undifferentiated cells. α-bisabolol also demonstrated a significant neuroprotective effect against amyloid β exposure, with β-caryophyllene also providing a lesser, but significant increase in cell viability. Protective effects of terpenes were more pronounced in undifferentiated versus differentiated cells, attributable more so to an attenuated loss of cell viability in response to Aβ1–42 following NSC-34 cell differentiation. Neuroprotection was associated with a direct inhibition of Aβ1–42 fibril and aggregate density, evidenced by both attenuated ThT fluorescence kinetics and both spectral and microscopic evidence of altered and diminished density of Aβ aggregates. While myrcene and β-caryophyllene also elicited reductions in ThT fluorescence and alterations in Aβ aggregation, these were less well associated with neuroprotective capacity. These findings highlight a neuroprotective role of α-bisabolol against Aβ-mediated neurotoxicity associated with an inhibition of Aβ fibrillization and modest antioxidant effect against lipid peroxidation, while β-caryophyllene also provided a small but significant measure of protection to Aβ-mediated neurotoxicity. Anti-aggregatory effects were not directly correlated with neuroprotective efficacy. This demonstrates that bioactivity of selected terpenes should be a consideration in the emergent use of medicinal cannabis formulations for the treatment of neurodegenerative diseases. [Display omitted] •Cannabis terpenes may have additional bioactivity to complement phytocannabinoids.•α-bisabolol and β-caryophyllene but not myrcene protected neuronal NSC-34 cells against neurotoxic amyloid β.•Neuroprotection was accompanied by modest attenuation in Aβ aggregation.•Bioactivity of terpenes may contribute to benefits of medicinal cannabis use in dementia and other CNS disorders.</description><subject>Agglomeration</subject><subject>Amyloid beta-Peptides - metabolism</subject><subject>Amyloid beta-Peptides - toxicity</subject><subject>Amyloid β</subject><subject>Animals</subject><subject>Antioxidants</subject><subject>Biocompatibility</subject><subject>Biological activity</subject><subject>Cannabis</subject><subject>Caryophyllene</subject><subject>Cell differentiation</subject><subject>Cell viability</subject><subject>Circular dichroism</subject><subject>Cytology</subject><subject>Density</subject><subject>Dichroism</subject><subject>Differentiation (biology)</subject><subject>Fibrillogenesis</subject><subject>Fluorescence</subject><subject>Hallucinogens</subject><subject>Incubation</subject><subject>Lipid peroxidation</subject><subject>Lipids</subject><subject>Medical marijuana</subject><subject>Monocyclic Sesquiterpenes</subject><subject>Myrcene</subject><subject>Myrcene, β-caryophyllene</subject><subject>Neurodegenerative diseases</subject><subject>Neuroprotection</subject><subject>Neuroprotective Agents - chemistry</subject><subject>Neuroprotective Agents - pharmacology</subject><subject>Neurotoxicity</subject><subject>Neurotoxicity Syndromes - prevention &amp; control</subject><subject>NSC-34</subject><subject>Oxidative stress</subject><subject>PC12 Cells</subject><subject>Peptide Fragments - toxicity</subject><subject>Peroxidation</subject><subject>Rats</subject><subject>Terpenes</subject><subject>Terpenes - toxicity</subject><subject>Toxicity testing</subject><subject>Transmission electron microscopy</subject><subject>α-bisabolol</subject><issn>0161-813X</issn><issn>1872-9711</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc-q1DAUxoso3vHqEwgScOOmNX_aJhVcyOA_uOhCBXchbU87GdNkTNLBPpa-h_eZTGeugi5cHELI73zny_my7CHBBcGkfrovLMzeFRRTWmBWYExuZRsiOM0bTsjtbJMokgvCPl9k90LYJ6DidXM3u2AV5aKi5Sb7uVXWqlYHFMEfwEJAvQ4HoxZ0VF6r1gA6eBehi_oISNk-VdS5GkcPo4rOL0ilN2cDUqPSNkR0shXdN92h6x9ITYtxukfaoqOO3j1DOz3uTKqo7Yji7q8BrXarXCIX5AZ0_T1P3lTrjDOrwpR0_UnfKpMb_QXQuw_bnJWoA2PC_ezOoEyABzfnZfbp1cuP2zf51fvXb7cvrvKOCR5zwTiuh6ZuOtYOjHBCcbpwRapKCVZzjDkWFTT1wLpSNLQpeccwFkD6lrcNZZfZk7Nucv51hhDlpMPqQFlwc5C0TnNoxViZ0Mf_oHs3--R-pXgp6rIWPFHsTHXeheBhkAevJ-UXSbBc05Z7efq2XNOWmMkUZup6dKM9txP0f3p-x5uA52cA0jKOGrwMnQbbQa99Wrjsnf7vgF8OqsFW</recordid><startdate>202205</startdate><enddate>202205</enddate><creator>Laws III, John Staton</creator><creator>Shrestha, Srijan</creator><creator>Smid, Scott D.</creator><general>Elsevier B.V</general><general>Elsevier BV</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>202205</creationdate><title>Cannabis terpenes display variable protective and anti-aggregatory actions against neurotoxic β amyloid in vitro: highlighting the protective bioactivity of α-bisabolol in motorneuronal-like NSC-34 cells</title><author>Laws III, John Staton ; Shrestha, Srijan ; Smid, Scott D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-83706f969c3bf3171209697a155a8367007085e96f3c4892947c3008e1db7b923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Agglomeration</topic><topic>Amyloid beta-Peptides - metabolism</topic><topic>Amyloid beta-Peptides - toxicity</topic><topic>Amyloid β</topic><topic>Animals</topic><topic>Antioxidants</topic><topic>Biocompatibility</topic><topic>Biological activity</topic><topic>Cannabis</topic><topic>Caryophyllene</topic><topic>Cell differentiation</topic><topic>Cell viability</topic><topic>Circular dichroism</topic><topic>Cytology</topic><topic>Density</topic><topic>Dichroism</topic><topic>Differentiation (biology)</topic><topic>Fibrillogenesis</topic><topic>Fluorescence</topic><topic>Hallucinogens</topic><topic>Incubation</topic><topic>Lipid peroxidation</topic><topic>Lipids</topic><topic>Medical marijuana</topic><topic>Monocyclic Sesquiterpenes</topic><topic>Myrcene</topic><topic>Myrcene, β-caryophyllene</topic><topic>Neurodegenerative diseases</topic><topic>Neuroprotection</topic><topic>Neuroprotective Agents - chemistry</topic><topic>Neuroprotective Agents - pharmacology</topic><topic>Neurotoxicity</topic><topic>Neurotoxicity Syndromes - prevention &amp; control</topic><topic>NSC-34</topic><topic>Oxidative stress</topic><topic>PC12 Cells</topic><topic>Peptide Fragments - toxicity</topic><topic>Peroxidation</topic><topic>Rats</topic><topic>Terpenes</topic><topic>Terpenes - toxicity</topic><topic>Toxicity testing</topic><topic>Transmission electron microscopy</topic><topic>α-bisabolol</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Laws III, John Staton</creatorcontrib><creatorcontrib>Shrestha, Srijan</creatorcontrib><creatorcontrib>Smid, Scott D.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Neurotoxicology (Park Forest South)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Laws III, John Staton</au><au>Shrestha, Srijan</au><au>Smid, Scott D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cannabis terpenes display variable protective and anti-aggregatory actions against neurotoxic β amyloid in vitro: highlighting the protective bioactivity of α-bisabolol in motorneuronal-like NSC-34 cells</atitle><jtitle>Neurotoxicology (Park Forest South)</jtitle><addtitle>Neurotoxicology</addtitle><date>2022-05</date><risdate>2022</risdate><volume>90</volume><spage>81</spage><epage>87</epage><pages>81-87</pages><issn>0161-813X</issn><eissn>1872-9711</eissn><abstract>Terpenes form a diverse class of naturally occurring chemicals ascribed various biological activities. Cannabis contains over 400 different terpenes of varying chemical complexity which may add to the known biological activities of phytocannabinoids of relevance to the increasing use of medical cannabis; however, to date have been incompletely characterized. We assessed three terpenes predominant in cannabis: α-bisabolol, myrcene and β-caryophyllene for neuroprotective and anti-aggregative properties in both undifferentiated and differentiated NSC-34 motorneuronal-like cells as a sensitive model for neurotoxicity to oxidative stress and amyloid β (Aβ1–42) protein exposure. Cell viability was assessed biochemically using the MTT assay in the presence of either α-bisabolol, myrcene and β-caryophyllene (1–1000 µM) for 48 hr. Sub-toxic threshold test concentrations of each terpene were then applied to cells, alone or with concomitant incubation with the lipid peroxidant tert-butyl hyrdroperoxide (t-BHP) or amyloid β (Aβ1–42; 0–1 µM) to assess neuroprotective effects. Direct effects of each terpene on Aβ fibril formation and aggregation were also evaluated using the Thioflavin T (ThT) fluorometric kinetic assay, circular dichroism and transmission electron microscopy (TEM) to visualise fibril and aggregate morphology. Terpenes were intrinsically benign to NSC-34 cells up to 100 µM. No significant antioxidant effects were observed following t-BHP administration with myrcene and β-caryophyllene, however α-bisabolol provided a modest but significant increase in cell viability in undifferentiated cells. α-bisabolol also demonstrated a significant neuroprotective effect against amyloid β exposure, with β-caryophyllene also providing a lesser, but significant increase in cell viability. Protective effects of terpenes were more pronounced in undifferentiated versus differentiated cells, attributable more so to an attenuated loss of cell viability in response to Aβ1–42 following NSC-34 cell differentiation. Neuroprotection was associated with a direct inhibition of Aβ1–42 fibril and aggregate density, evidenced by both attenuated ThT fluorescence kinetics and both spectral and microscopic evidence of altered and diminished density of Aβ aggregates. While myrcene and β-caryophyllene also elicited reductions in ThT fluorescence and alterations in Aβ aggregation, these were less well associated with neuroprotective capacity. These findings highlight a neuroprotective role of α-bisabolol against Aβ-mediated neurotoxicity associated with an inhibition of Aβ fibrillization and modest antioxidant effect against lipid peroxidation, while β-caryophyllene also provided a small but significant measure of protection to Aβ-mediated neurotoxicity. Anti-aggregatory effects were not directly correlated with neuroprotective efficacy. This demonstrates that bioactivity of selected terpenes should be a consideration in the emergent use of medicinal cannabis formulations for the treatment of neurodegenerative diseases. [Display omitted] •Cannabis terpenes may have additional bioactivity to complement phytocannabinoids.•α-bisabolol and β-caryophyllene but not myrcene protected neuronal NSC-34 cells against neurotoxic amyloid β.•Neuroprotection was accompanied by modest attenuation in Aβ aggregation.•Bioactivity of terpenes may contribute to benefits of medicinal cannabis use in dementia and other CNS disorders.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>35278524</pmid><doi>10.1016/j.neuro.2022.03.001</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0161-813X
ispartof Neurotoxicology (Park Forest South), 2022-05, Vol.90, p.81-87
issn 0161-813X
1872-9711
language eng
recordid cdi_proquest_miscellaneous_2638725334
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Agglomeration
Amyloid beta-Peptides - metabolism
Amyloid beta-Peptides - toxicity
Amyloid β
Animals
Antioxidants
Biocompatibility
Biological activity
Cannabis
Caryophyllene
Cell differentiation
Cell viability
Circular dichroism
Cytology
Density
Dichroism
Differentiation (biology)
Fibrillogenesis
Fluorescence
Hallucinogens
Incubation
Lipid peroxidation
Lipids
Medical marijuana
Monocyclic Sesquiterpenes
Myrcene
Myrcene, β-caryophyllene
Neurodegenerative diseases
Neuroprotection
Neuroprotective Agents - chemistry
Neuroprotective Agents - pharmacology
Neurotoxicity
Neurotoxicity Syndromes - prevention & control
NSC-34
Oxidative stress
PC12 Cells
Peptide Fragments - toxicity
Peroxidation
Rats
Terpenes
Terpenes - toxicity
Toxicity testing
Transmission electron microscopy
α-bisabolol
title Cannabis terpenes display variable protective and anti-aggregatory actions against neurotoxic β amyloid in vitro: highlighting the protective bioactivity of α-bisabolol in motorneuronal-like NSC-34 cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T00%3A44%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cannabis%20terpenes%20display%20variable%20protective%20and%20anti-aggregatory%20actions%20against%20neurotoxic%20%CE%B2%20amyloid%20in%20vitro:%20highlighting%20the%20protective%20bioactivity%20of%20%CE%B1-bisabolol%20in%20motorneuronal-like%20NSC-34%20cells&rft.jtitle=Neurotoxicology%20(Park%20Forest%20South)&rft.au=Laws%20III,%20John%20Staton&rft.date=2022-05&rft.volume=90&rft.spage=81&rft.epage=87&rft.pages=81-87&rft.issn=0161-813X&rft.eissn=1872-9711&rft_id=info:doi/10.1016/j.neuro.2022.03.001&rft_dat=%3Cproquest_cross%3E2638725334%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2674864687&rft_id=info:pmid/35278524&rft_els_id=S0161813X22000377&rfr_iscdi=true